Global Infection Detection Solutions Market Growth (Status and Outlook) 2025-2031

The global Infection Detection Solutions market size is predicted to grow from US$ 47940 million in 2025 to US$ 82640 million in 2031; it is expected to grow at a CAGR of 9.5% from 2025 to 2031.

Infection Detection Solutions refer to a range of technologies, tools, and methods used to identify the presence of infectious agents (like bacteria, viruses, fungi, etc.) in a body, environment, or materials. These solutions typically involve diagnostic tests or systems designed to detect infections at early stages, enabling timely medical intervention.

United States market for Infection Detection Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Infection Detection Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Infection Detection Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Infection Detection Solutions players cover Qiagen, Abbott, Siemens, Bio-Rad, Mindray, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Infection Detection Solutions Industry Forecast” looks at past sales and reviews total world Infection Detection Solutions sales in 2024, providing a comprehensive analysis by region and market sector of projected Infection Detection Solutions sales for 2025 through 2031. With Infection Detection Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infection Detection Solutions industry.

This Insight Report provides a comprehensive analysis of the global Infection Detection Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infection Detection Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infection Detection Solutions market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infection Detection Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infection Detection Solutions.

This report presents a comprehensive overview, market shares, and growth opportunities of Infection Detection Solutions market by product type, application, key players and key regions and countries.

Segmentation by Type:
Blood Test
Urine Test
Stool Sample
Others

Segmentation by Application:
Hospital
Center for Disease Control and Prevention
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Qiagen
Abbott
Siemens
Bio-Rad
Mindray
QuidelOrtho
Thermo Fischer Scientific
Eurofins Viracor
Roche
BioMerieux
Autobio
Kpsontech
Beckman Coulter
Becton Dickinson

Please note: The report will take approximately 2 business days to prepare and deliver. Show more